Nara, Japan

Yutaka Takagaki

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Iatron Laboratories Inc., Osaka-Fu. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Takagaki. Retrieved from https://idiyas.com/inventor/yutaka-takagaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yutaka Takagaki: A Pioneer in Immunoassay Technology

Introduction

Yutaka Takagaki is a renowned inventor based in Nara, Japan, known for his contributions to the field of immunoassays. As an innovative thinker, he has made significant strides in biotechnology, particularly through his work on monoclonal antibodies and hybridomas.

Latest Patents

Yutaka Takagaki holds one patent, which focuses on immunoassay technology utilizing monoclonal antibodies and hybridomas. This invention represents a key advancement in diagnostic testing, helping to improve the accuracy and efficiency of medical assessments.

Career Highlights

Throughout his career, Takagaki has been associated with prestigious organizations such as Iatron Laboratories Inc. and Osaka-fu. His work in these institutions has contributed immensely to the development of new medical technologies and innovations. His commitment to research and development has positioned him as a pivotal figure in his field.

Collaborations

Yutaka Takagaki has collaborated with notable professionals, including Shiro Matsuura and Yonekazu Hamano. These partnerships have enabled him to enhance his research efforts and further push the boundaries of immunoassay technology, contributing to significant advancements in the biotechnology sector.

Conclusion

In conclusion, Yutaka Takagaki's innovative contributions to immunoassay technology underscore his importance as an inventor. His patent on monoclonal antibodies and hybridomas marks a significant achievement that benefits the medical field. With ongoing collaborations and a strong foundation in research, Takagaki continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…